Ticker Details
Zentalis Pharmaceuticals, Inc.
IPO Date:	April 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$156.7M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.82 | 3.46%
Avg Daily Range (30 D):	$0.13 | 4.50%
Avg Daily Range (90 D):	$0.08 | 3.85%

Institutional Daily Volume
Avg Daily Volume:	.64M
Avg Daily Volume (30 D):	1.27M
Avg Daily Volume (90 D):	1.09M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	147
Avg Trade Size (Sh.) (90 D):	193

Institutional Trades
Total Institutional Trades:	1,919
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$2.27M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$.74M
Avg Closing Trade (90 D):	$.74M
Avg Closing Volume:	121.31K

News

Jan 12, 2026 @ 3:35 PM Fast-Tracking the $537B Cancer Cure: How Accelerat... Source: Prnewswire

Dec 17, 2025 @ 2:00 PM Incyclix Bio Expands Board of Directors with Appoi... Source: Tony Plohoros

Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold

Aug 7, 2025 @ 12:28 AM Zentalis (ZNTL) Q2 Loss Narrows 70% Source: Jesterai

Jul 1, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.07	$-.37	$-.37
Diluted EPS	$-2.07	$-.37	$-.37
Revenue	$26.87M	$M	$M
Gross Profit
Net Income / Loss	$-149.32M	$-26.69M	$-26.87M
Operating Income / Loss	$-165.26M	$-33.73M	$-36.06M
Cost of Revenue
Net Cash Flow	$-2.25M	$1.47M	$-4.33M
PE Ratio